[ TRANSACTION RECORD ]

Novo Nordisk Foundation Investment in Metabolic Drug Hub — 2026

VERIFIED VECTOR ID: 002674 · tx-389
M SOURCE NODE — FUNDER
Novo Nordisk Foundation
Healthcare Denmark
$1,400,000,000
EQUITY
15/04/2026
Q DESTINATION NODE — RECIPIENT
Metabolic Drug Hub
SPV Denmark
Amount (USD)
$1.4B
Flow Type
EQUITY
Transaction Date
15/04/2026
Primary Source
View Filing ↗
Funder Profile [ M ]
Entity Novo Nordisk Foundation
AUM 130000
HQ Location Denmark
Sector Healthcare
Recipient Profile [ Q ]
Entity Metabolic Drug Hub
Entity Type SPV
Jurisdiction Denmark
Intelligence Note

Novo Holdings A/S finalized a 1.4 billion dollar equity investment to expand the Metabolic Drug Hub in Denmark to increase the global production of obesity therapies. This transaction supports the installation of advanced bioreactors and automated packaging lines. The deal is a strategic move to secure the supply chain for world-class health therapies.

Σ
Primary Forensic Source https://www.novoholdings.dk/news/novo-holdings-to-expand-metabolic-drug-hub/
✓ SOURCE LINKED